Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Agilon Health Inc (AGL)

Agilon Health Inc (AGL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,647,101
  • Shares Outstanding, K 406,731
  • Annual Sales, $ 1,834 M
  • Annual Income, $ -406,490 K
  • 60-Month Beta 2.84
  • Price/Sales 4.79
  • Price/Cash Flow N/A
  • Price/Book 7.88
Trade AGL with:

Options Overview Details

View History
  • Implied Volatility 76.98% ( +2.62%)
  • Historical Volatility 64.04%
  • IV Percentile 72%
  • IV Rank 53.35%
  • IV High 112.55% on 05/12/22
  • IV Low 36.30% on 08/26/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 67
  • Volume Avg (30-Day) 877
  • Put/Call OI Ratio 1.52
  • Today's Open Interest 22,354
  • Open Int (30-Day) 20,055

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.02
  • Number of Estimates 6
  • High Estimate -0.01
  • Low Estimate -0.05
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.41 +25.39%
on 06/16/22
22.54 -3.15%
on 06/24/22
+2.13 (+10.81%)
since 05/27/22
3-Month
14.82 +47.30%
on 05/10/22
26.31 -17.03%
on 04/04/22
-2.97 (-11.98%)
since 03/30/22
52-Week
14.36 +52.02%
on 01/28/22
40.57 -46.19%
on 07/01/21
-18.74 (-46.19%)
since 06/30/21

Most Recent Stories

More News
Angle PLC Announces Result of 2022 Annual General Meeting

GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
agilon health Appoints Denise Zamore as Chief Legal Officer

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced the appointment of Denise Zamore as the company’s first Chief Legal Officer...

AGL : 21.83 (+2.68%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
Angle PLC Announces Secured Contract From Pharma Services Customer

Additional contract for a new clinical trial

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
Angle PLC Announces Predicting Immunotherapy Response in SCLC

PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
Angle PLC Announces Potential Role of Invasive Cellular Protrusions

Prostate cancer cells may use invasive cellular protrusions to aid entry into the blood stream, a potential target in the metastatic process for novel therapy development

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
agilon health to Participate in the William Blair 42nd Annual Growth Stock Conference

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the William Blair 42 nd Annual Growth Stock Conference,...

AGL : 21.83 (+2.68%)
Angle PLC Announces Partnership with Major United States Urology Group

PARTNERSHIP ESTABLISHED WITH A MAJOR UNITED STATES UROLOGY GROUP TO CONDUCT CLINICAL STUDIES IN PROSTATE CANCER AND AS A POTENTIAL ROUTE TO MARKET

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
Angle PLC Announces Molecular Characterisation of CTCs

Parsortix system harvests intact CTCs for single-cell whole genomic sequencing from frozen and fresh blood samples with the same efficiency

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)
ANGLE receives FDA clearance for Parsortix

ANGLE ACHIEVES WORLD FIRST WITH FDA CLEARANCE FOR ITS PARSORTIX SYSTEMFDA De Novo product clearance to harvest cancer cells from blood for subsequent analysis offers the prospect of a new era of personalised...

AGL : 21.83 (+2.68%)
ANPCY : 12.5400 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 23.35
2nd Resistance Point 22.63
1st Resistance Point 22.23
Last Price 21.83
1st Support Level 21.11
2nd Support Level 20.39
3rd Support Level 19.99

See More

52-Week High 40.57
Fibonacci 61.8% 30.56
Fibonacci 50% 27.47
Fibonacci 38.2% 24.37
Last Price 21.83
52-Week Low 14.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar